propranolol has been researched along with Benign Cerebellar Neoplasms in 2 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol is a valid treatment for large cranial hemangiomas, avoiding the risks involved in surgeries." | 7.81 | Giant cranial and cerebellar hemangioma treated with propranolol. ( Ben-Sira, L; Benvenisti, H; Constantini, S; Roth, J, 2015) |
| "HeLa 9X (HRE) hypoxia responsive element cell line and primary hemangioblastoma-derived cells were subjected to propranolol treatment and cell viability and apoptosis were evaluated." | 7.81 | Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. ( Albiñana, V; Botella, LM; de Campos, JM; Mota-Pérez, M; Perona-Moratalla, AB; Segura, T; Serrano-Heras, G; Villar Gómez de Las Heras, K, 2015) |
| "Propranolol is a valid treatment for large cranial hemangiomas, avoiding the risks involved in surgeries." | 3.81 | Giant cranial and cerebellar hemangioma treated with propranolol. ( Ben-Sira, L; Benvenisti, H; Constantini, S; Roth, J, 2015) |
| "HeLa 9X (HRE) hypoxia responsive element cell line and primary hemangioblastoma-derived cells were subjected to propranolol treatment and cell viability and apoptosis were evaluated." | 3.81 | Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. ( Albiñana, V; Botella, LM; de Campos, JM; Mota-Pérez, M; Perona-Moratalla, AB; Segura, T; Serrano-Heras, G; Villar Gómez de Las Heras, K, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benvenisti, H | 1 |
| Ben-Sira, L | 1 |
| Constantini, S | 1 |
| Roth, J | 1 |
| Albiñana, V | 1 |
| Villar Gómez de Las Heras, K | 1 |
| Serrano-Heras, G | 1 |
| Segura, T | 1 |
| Perona-Moratalla, AB | 1 |
| Mota-Pérez, M | 1 |
| de Campos, JM | 1 |
| Botella, LM | 1 |
2 other studies available for propranolol and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Giant cranial and cerebellar hemangioma treated with propranolol.
Topics: Adrenergic beta-Antagonists; Cerebellar Neoplasms; Female; Hemangioma; Humans; Infant, Newborn; Prop | 2015 |
Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Apoptosis; Cell Survival; Cerebellar Neoplasms; Dose | 2015 |